Maple Rock Capital Partners Inc. Bausch Health Companies Inc. Transaction History
Maple Rock Capital Partners Inc.
- $3.18 Billion
- Q4 2024
A detailed history of Maple Rock Capital Partners Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Maple Rock Capital Partners Inc. holds 5,300,000 shares of BHC stock, worth $38.1 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
5,300,000
Previous 2,064,900
156.67%
Holding current value
$38.1 Million
Previous $16.8 Million
153.85%
% of portfolio
1.34%
Previous 0.49%
Shares
2 transactions
Others Institutions Holding BHC
# of Institutions
270Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$249 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$198 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$190 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$111 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$93.3 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.6B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...